|1.||Murat, Samy: 1 article (05/2014)|
|2.||Prézeau, Laurent: 1 article (05/2014)|
|3.||Bockaert, Joël: 1 article (05/2014)|
|4.||Millan, Mark J: 1 article (05/2014)|
|5.||Vandermoere, Franck: 1 article (05/2014)|
|6.||Marin, Philippe: 1 article (05/2014)|
|7.||Mannoury la Cour, Clotilde: 1 article (05/2014)|
|8.||Becamel, Carine: 1 article (05/2014)|
|9.||Karaki, Samah: 1 article (05/2014)|
|10.||Prue, Bob: 1 article (03/2014)|
|1.||Schizophrenia (Dementia Praecox)
05/01/1968 - "Studies on mescaline XIX: a new theory concernig the nature of schizophrenia."
07/01/1957 - "The effects of mescaline sulfate in chronic schizophrenia."
09/01/1951 - "VIII. Experimental tests in schizophrenia; lysergic acid diethylamide and mescaline]."
08/25/1951 - "VIII. Experimental tests in schizophrenia: lysergic acid diethylamide and mescaline]."
09/01/1989 - "Three disorders of facial recognition and perception in acute schizophrenia and mescaline-induced psychosis are described and illustrated using original clinical and experimental material: "affective prosopagnosia" or stress-related dysfunctional face recognition; "physiognomization" of the environment or persistent illusions and hallucinations of nonspecific faces; and the "mirror phenomenon" or the experience of inner alienation from one's reflected face, which is perceived as independently alive, sinister, and generally physically distorted. "
|2.||Substance-Related Disorders (Drug Abuse)
01/01/2006 - "The results of this exploratory study suggest that illicit peyote use is uncommon among AI adolescents with serious substance abuse problems."
03/01/2014 - "Peyote was classified as a hallucinogen in the Drug Abuse Control Act of 1965, leaving American Indian (AI) religious use in legal ambiguity. "
01/01/2006 - "Illicit peyote users did not differ from nonusers in terms of age, gender, other substance use, prevalence of either other substance abuse/dependence or other nonsubstance use psychiatric disorders. "
01/01/2006 - "Illicit peyote use among American Indian adolescents in substance abuse treatment: a preliminary investigation."
11/01/1977 - "This cactus species has a mescaline content equal or superior to peyote and should be legally controlled as an item of drug abuse."
|3.||Mental Disorders (Mental Disorder)
07/01/1961 - "On the similarity between hypnotic and mescaline hallucinations."
02/08/1952 - "[Disorders of space and time perception with special reference to mescaline hallucinations]."
03/01/1950 - "Hallucination and imagery induced by mescaline."
01/01/1947 - "Investigation of the psycho-chemical basis of visual hallucinations produced by mescaline."
10/01/1948 - "The effect of succinate in mescaline hallucinations."
01/01/1981 - "These experiments demonstrate an interaction between shock, which presumably is a stressor, and mescaline. "
01/01/1981 - "Mescaline given to shock rats had no effect on acquisition even though levels of acquisition were the same for both shock and nonshock rats without drug. "
01/01/1981 - "Inescapable shock alters mescaline's disruption of active avoidance acquisition."
05/01/1978 - "Several measures of aggressive behavior were investigated in three ages (40-50, 90-110, and 180-200 days old) and in three strains (Sprague-Dawley, Wistar, and Long-Evans) of rats before and following the administration of mescaline hydrochloride in a shock-elicited aggression situation. "
12/01/1977 - "Untreated rats develop "pathological" aggression when paired with a mescaline-treated rat in a shock-elicited aggression situation."
|2.||Lysergic Acid Diethylamide (LSD)
|5.||Serotonin (5 Hydroxytryptamine)
|6.||5-HT2A Serotonin Receptor (5 HT2A Receptor)
|8.||Phencyclidine (Angel Dust)